Clinical Trial Update: A Study to Evaluate Safety, PK and Efficacy of GH55 in Combination With GH21 in Patients With Solid Tumors [Phase 1, Phase 2]

View source ↗

Summary

A phase 1/2 clinical trial to evaluate safety, pharmacokinetics, and efficacy of GH55 in combination with GH21 in patients with advanced solid tumors; the study…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• GH21
• GH55

Snippet

Sponsor: Suzhou Genhouse Bio Co., Ltd. | Conditions: Advanced Solid Tumor Cancer | Phase 1, Phase 2 | Status: NOT_YET_RECRUITING